[1]
2015. EFFICACY AND SAFETY OF CLADRIBINE: SUBCUTANEOUS VERSUS INTRAVENOUS ADMINISTRATION IN HAIRY CELL LEUKEMIA PATIENTS. Mediterranean Journal of Hematology and Infectious Diseases. 7, 1 (Oct. 2015), e2015058. DOI:https://doi.org/10.4084/mjhid.2015.058.